Výsledky vyhledávání - Jeremy Cobbold
- Zobrazuji výsledky 1 - 20 z 30
- Přejít na další stránku
-
1
Non-alcoholic fatty liver disease and diabetes Autor Jonathan Hazlehurst, Conor Woods, Thomas Marjot, Jeremy Cobbold, Jeremy Tomlinson
Vydáno 2016Revisão -
2
-
3
-
4
-
5
-
6
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health Autor Ahmad Moolla, Kenzo Motohashi, Thomas Marjot, Amelia Shard, Mark Ainsworth, Alastair Gray, Rury R. Holman, Michael Pavlides, John Ryan, Jeremy Tomlinson, Jeremy Cobbold
Vydáno 2019Artigo -
7
Multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease severity Autor Michael Pavlides, Rajarshi Banerjee, Elizabeth M. Tunnicliffe, Matt Kelly, Jane Collier, Lai Mun Wang, K A Fleming, Jeremy Cobbold, Matthew D. Robson, Stefan Neubauer, Eleanor Barnes
Vydáno 2016Artigo -
8
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis Autor Dimitrios A. Koutoukidis, Sandi Yen, Paula Gomez Castro, Mariya Misheva, Susan A. Jebb, Paul Aveyard, Jeremy Tomlinson, Ferenc Mózes, Jeremy Cobbold, Jethro S. Johnson, Julian R. Marchesi
Vydáno 2024Artigo -
9
Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease Autor Arjun Jayaswal, Christina Levick, Emmanuel Selvaraj, Andrea Dennis, Jonathan Booth, Jane Collier, Jeremy Cobbold, Elizabeth M. Tunnicliffe, Matt Kelly, Eleanor Barnes, Stefan Neubauer, Rajarshi Banerjee, Michael Pavlides
Vydáno 2020Artigo -
10
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Autor Peter Eddowes, M. Sasso, Michael Allison, Emmanuel Tsochatzis, Quentin M. Anstee, David Sheridan, Indra Neil Guha, Jeremy Cobbold, Jonathan J Deeks, Valérie Paradis, Pierre Bédossa, Philip N. Newsome
Vydáno 2019Artigo -
11
Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD Autor Ahmad Moolla, Toryn Poolman, Nantia Othonos, Jiawen Dong, Kieran Smith, Thomas Cornfield, Sarah J. White, David Ray, Sofia Mouchti, Ferenc Mózes, Helena Thomaides‐Brears, Stefan Neubauer, Jeremy Cobbold, Leanne Hodson, Jeremy Tomlinson
Vydáno 2025Artigo -
12
Hepatic iron is the major determinant of serum ferritin in <scp>NAFLD</scp> patients Autor John Ryan, Andrew E. Armitage, Jeremy Cobbold, Rajarshi Banerjee, Oscar Borsani, Paola Dongiovanni, Stefan Neubauer, R Morovat, Lai Mun Wang, Sant‐Rayn Pasricha, Silvia Fargion, Jane Collier, Eleanor Barnes, Hal Drakesmith, Luca Valenti, Michael Pavlides
Vydáno 2017Artigo -
13
Raised Hepatic Bile Acid Concentrations During Pregnancy in Mice Are Associated with Reduced Farnesoid X Receptor Function Autor Alexandra Milona, Bryn M. Owen, Jeremy Cobbold, Ellen C.L. Willemsen, I. Jane Cox, Mohamed Boudjelal, William Cairns, Kristina Schoonjans, Simon D. Taylor‐Robinson, Leo W. J. Klomp, Malcolm G. Parker, Roger White, Saskia W. C. van Mil, Catherine Williamson
Vydáno 2010Artigo -
14
PYY plays a key role in the resolution of diabetes following bariatric surgery in humans Autor Claudia Guida, Sam D. Stephen, Michael Watson, Niall Dempster, Pierre Larraufie, Thomas Marjot, Tamsin Cargill, Lisa Rickers, Michael Pavlides, Jeremy Tomlinson, Jeremy Cobbold, Chun‐Mei Zhao, Duan Chen, Fiona M. Gribble, Frank Reimann, Richard Gillies, Bruno Sgromo, Patrik Rorsman, John Ryan, Reshma Ramracheya
Vydáno 2019Artigo -
15
Rifaximin in non‐alcoholic steatohepatitis: An open‐label pilot study Autor Jeremy Cobbold, Stephen R. Atkinson, Julian R. Marchesi, Ann Smith, Sann N. Wai, J Stove, Fariba Shojaee‐Moradie, Nicola Jackson, A. Margot Umpleby, Julie Fitzpatrick, E. Louise Thomas, Jimmy D. Bell, Elaine Holmes, Simon D. Taylor‐Robinson, Robert Goldin, Michael Yee, Quentin M. Anstee, Mark Thursz
Vydáno 2017Artigo -
16
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information Autor Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M. Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero‐Gómez, Jean‐François Dufour, Mattias Ekstedt, Sven Francque, Hannele Yki‐Järvinen, Michael Allison, Luca Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, George Papatheodoridis, Adriaan G. Holleboom, Dina Tiniakos, Clifford A. Brass, Quentin M. Anstee, Paolo Missier
Vydáno 2024Artigo -
17
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and g... Autor Philip N. Newsome, M. Sasso, Jonathan J Deeks, Angelo H. Paredes, Jérôme Boursier, Wah‐Kheong Chan, Yusuf Yılmaz, Sébastien Czernichow, Ming‐Hua Zheng, Vincent Wai‐Sun Wong, Michael Allison, Emmanuel Tsochatzis, Quentin M. Anstee, David Sheridan, Peter Eddowes, Indra Neil Guha, Jeremy Cobbold, Valérie Paradis, Pierre Bédossa, Véronique Miette, Céline Fournier‐Poizat, Laurent Sandrin, Stephen Harrison
Vydáno 2020Artigo -
18
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Soc... Autor Stuart McPherson, Matthew J. Armstrong, Jeremy Cobbold, Lynsey Corless, Quentin M. Anstee, Richard Aspinall, Stephen T. Barclay, Paul Brennan, Tessa Cacciottolo, Robert Goldin, Kate Hallsworth, Vanessa Hebditch, Kathryn Jack, Helen Jarvis, Jill L. Johnson, Wenhao Li, Dina Mansour, Mary McCallum, Ashis Mukhopadhya, Richard Parker, Valerie Ross, Ian Rowe, Ankur Srivastava, Prarthana Thiagarajan, Alexandra Thompson, Jeremy Tomlinson, Emmanuel Tsochatzis, Andrew D. Yeoman, William Alazawi
Vydáno 2022Revisão -
19
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease Autor Timothy Hardy, Kristy Wonders, Ramy Younes, Guruprasad P. Aithal, R. Aller, Michael Allison, Pierre Bédossa, Fay Betsou, Jérôme Boursier, M. Julia Brosnan, Alastair D. Burt, Jeremy Cobbold, Helena Cortez‐Pinto, Chris Day, Jean‐François Dufour, Mattias Ekstedt, Sven Francque, Stephen A. Harrison, Luca Miele, Patrik Nasr, George Papatheodoridis, Salvatore Petta, Dina Tiniakos, Richard Torstenson, Luca Valenti, Adriaan G. Holleboom, Hannele Yki‐Järvinen, Andreas Geier, Manuel Romero‐Gómez, Vlad Ratziu, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee
Vydáno 2020Artigo -
20
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis Autor David Petroff, Valentin Blank, Philip N. Newsome, S. Shalimar, Cosmin Sebastian Voican, Maja Thiele, Victor de Lédinghen, Stephan Baumeler, Wah‐Kheong Chan, Gabriel Perlemuter, A.C. Cardoso, Sandeep Aggarwal, M. Sasso, Peter Eddowes, Michael Allison, Emmanuel Tsochatzis, Quentin M. Anstee, David Sheridan, Jeremy Cobbold, Sylvie Naveau, Monica Lupșor‐Platon, Sebastian Mueller, Aleksander Krag, Marie Irlès‐Depé, David Semela, Grace Lai‐Hung Wong, Vincent Wai‐Sun Wong, Cristiane Alves Villela‐Nogueira, Harshit Garg, Olivier Chazouillères, Johannes Wiegand, Thomas Karlas
Vydáno 2021Revisão
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Disease
Fatty liver
Gastroenterology
Cirrhosis
Endocrinology
Steatohepatitis
Fibrosis
Nonalcoholic fatty liver disease
Biology
Transient elastography
Biopsy
Cohort
Liver biopsy
Liver disease
Biochemistry
Diabetes mellitus
Liver fibrosis
Pathology
Receptor
Steatosis
Agonist
Alcoholic liver disease
Artificial intelligence
Chemistry
Clinical trial
Computer science
Genetics
Hepatology